Search details
1.
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology.
Cancer Immunol Immunother
; 68(1): 143-150, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30564888
2.
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5-7, 2017.
Cancer Immunol Immunother
; 68(1): 151-158, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30094463
3.
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13-15, 2016.
Cancer Immunol Immunother
; 67(6): 1023-1030, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29058034
4.
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines.
Eur J Cancer
; 171: 143-149, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35717822
5.
"Cancer Bio-Immunotherapy in Siena": Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8-10, 2015.
Cancer Immunol Immunother
; 65(11): 1423-1431, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27619513
6.
Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival.
Cancers (Basel)
; 12(2)2020 Feb 05.
Article
in English
| MEDLINE | ID: mdl-32033266
7.
Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy.
Front Pharmacol
; 9: 1443, 2018.
Article
in English
| MEDLINE | ID: mdl-30581389
8.
Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients.
Oncoimmunology
; 6(7): e1323618, 2017.
Article
in English
| MEDLINE | ID: mdl-28811958
9.
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix.
Eur J Cancer
; 156: 119-121, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34428684
Results
1 -
9
de 9
1
Next >
>>